Discussion
People with atypical hemolytic uremic syndrome (aHUS) consider treatment effectiveness and safety as top priorities when choosing medications, an international survey showed. Most patients also said they would prefer oral therapies and less frequent dosing. The findings, based on responses from 122 patients, revealed a substantial burden from treatment-related…